Gujarat Kidney And Super Speciality valuation

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026
Price multiples — at each FY-end close
85.40×—
5.35×—
13.38×—
Enterprise multiples
13.43×—
50.83×—
63.06×—
Yield
1.2%—
−1.1%—
Reference — adjusted share basis
₹171.50—
₹2.01₹1.97
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

GKSL₹171.50

Gujarat Kidney And Super Speciality Limited

· Pharma & Health
₹ CrorePeersGPTHEALTHSHALBYINDRAMEDCOLOTUSEYEARTEMISMEDDRAGARWQKMCSHILKOVAIMcap ₹1,352 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY26
31/03/2026
Current/LTM
TTM · last close
Price Multiples — at each FY-end close
P/E—85.40
P/B—5.35
P/Sales—13.38
Enterprise Multiples
EV/Sales—13.43
EV/EBITDA—50.83
EV/EBIT—63.06
Yield
Earnings Yield %—1.17
FCF Yield %—-1.09
Reference — adjusted share basis
Price (FY-end close, adj.)—171.50
EPS (adj.)1.972.01
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.